Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Pedersen, Michael ^a   Benfield, Thomas L ^a   Skinhoej, Peter ^a   Jensen, Allan Garlik ^a,b  

^a Rigshospitalet   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; METICILLIN; PENICILLIN G; STREPTOMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; CHILD; CLINICAL FEATURE; CONFIDENCE INTERVAL; CRITICAL ILLNESS; DEMOGRAPHY; DENMARK; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NONHUMAN; PREDICTION; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; SEPSIS; STAPHYLOCOCCUS AUREUS; BACTEREMIA; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; DENMARK; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 33645463532     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-49     Document Type: Article

References (32)

1. Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N: Staphylococcus aureus meningitis. A review of 104 nationwide, consecutive cases. Arch Intern Med 1993, 153:1902-1908.
2. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VSJ, Swartz MN: Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993, 328:21-28.
3. Norgaard M, Gudmundsdottir G, Larsen CS, Schonheyder HC: Staphylococcus aureus meningitis: experience with cefuroxime treatment during a 16 year period in a Danish region. Scand J Infect Dis 2003, 35:311-314.
4. Schlesinger LS, Ross SC, Schaberg DR: Staphylococcus aureus meningitis: a broad-based epidemiologic study. Medicine (Baltimore) 1987, 66:148-156.
5. Lerche A, Rasmussen N, Wandall JH, Bohr VA: Staphylococcus aureus meningitis: a review of 28 consecutive community-acquired cases. Scand J Infect Dis 1995, 27:569-573.
6. Chang WN, Lu CH, Wu JJ, Chang HW, Tsai YC, Chen FT, Chien CC: Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Infection 2001, 29:245-250.
7. Pintado V, Meseguer MA, Fortun J, Cobo J, Navas E, Quereda C, Corral I, Moreno S: Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur J Clin Microbiol Infect Dis 2002, 21:864-868.
8. Fong IW, Ranalli P: Staphylococcus aureus meningitis. Q J Med 1984, 53:289-299.
9. Danmark Statistik [http://www.dst.dk].
10. Chow JW, Yu VL: Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999, 11:7-12.
11. Lemeshow S, Hosmer DWJ: A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982, 115:92-106.
12. Meyer CN, Samuelsson IS, Galle M, Bangsborg JM: Adult bacterial meningitis: aetiology, penicillin susceptibility, risk factors, prognostic factors and guidelines for empirical antibiotic treatment. Clin Microbiol Infect 2004, 10:709-717.
13. Huang CR, Lu CH, Wu JJ, Chang HW, Chien CC, Lei CB, Chang WN: Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes. Infection 2005, 33:56-60.
14. Wang JT, Hung CC, Sheng WH, Wang JY, Chang SC, Luh KT: Prognosis of tuberculous meningitis in adults in the era of modern antituberculous chemotherapy. J Microbiol Immunol Infect 2002, 35:215-222.
15. Ostergaard C, Konradsen HB, Samuelsson S: Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC Infect Dis 2005, 5:93.
16. Zahran HS, Kobau R, Moriarty DG, Zack MM, Holt J, Donehoo R: Health-related quality of life surveillance - United States, 1993-2002. MMWR Surveill Summ 2005, 54:1-35.
17. Alexander EH, Hudson MC: Factors influencing the internalization of Staphylococcus aureus and impacts on the course of infections in humans. Appl Microbiol Biotechnol 2001, 56:361-366.
18. Bradley SF: Staphylococcus aureus infections and antibiotic resistance in older adults. Clin Infect Dis 2002, 34:211-216.
19. Jensen AG: Importance of focus identification in the treatment of Staphylococcus aureus bacteraemia. J Hosp Infect 2002, 52:29-36.
20. Devlin RK, Andrews MM, von Reyn CF: Recent trends in infective endocarditis: influence of case definitions. Curr Opin Cardiol 2004, 19:134-139.
21. Roder BL, Wandall DA, Espersen F, Frimodt-Moller N, Skinhoj P, Rosdahl VT: Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med 1997, 102:379-386.
22. Angstwurm K, Halle E, Wetzel K, Schultze J, Schielke E, Weber JR: Isolated bacterial meningitis as the key syndrome of infective endocarditis. Infection 2004, 32:47-50.
23. Nolla JM, Ariza J, Gomez-Vaquero C, Fiter J, Bermejo J, Valverde J, Escofet DR, Gudiol F: Spontaneous pyogenic vertebral osteomyelitis in nondrug users. Semin Arthritis Rheum 2002, 31:271-278.
24. Mizock BA: Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001, 15:533-551.
25. Kim JH, van der HC, Mulrow CD, Corey GR. Staphylococcus aureus meningitis: review of 28 cases. Rev Infect Dis 1989, 11:698-706.
26. Mylotte JM, Tayara A: Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000, 31:1170-1174.
27. Hill PC, Birch M, Chambers S, Drinkovic D, Ellis-Pegler RB, Everts R, Murdoch D, Pottumarthy S, Roberts SA, Swager C, Taylor SL, Thomas MG, Wong CG, Morris AJ: Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 2001, 31:97-103.
28. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426-2432.
29. Preiser JC, Devos P, Van den BG: Tight control of glycaemia in critically ill patients. Curr Opin Clin Nutr Metab Care 2002, 5:533-537.
30. Gordon JJ, Harter DH, Phair JP: Meningitis due to Staphylococcus aureus. Am J Med 1985, 78:965-970.
31. van de BD, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M: Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004, 351:1849-1859.
32. Zimmerli W: Acute bacterial meningitis: time for a better outcome. Intensive Care Med 2003, 29:1868-1870.